☰

Julie C. DiCarlo, Ph.D. - Publications

Affiliations: 
2006 Stanford University, Palo Alto, CA 
Area:
Electronics and Electrical Engineering, Biomedical Engineering, Radiology
Tree Info Similar researchers PubMed Report error

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Peterfy C, DiCarlo J, Emery P, Genovese MC, Keystone EC, Taylor PC, Schlichting DE, Beattie SD, Luchi M, Macias W. Use of Magnetic Resonance Imaging to Support Dose Selection in a Phase II Trial of Baricitinib Combined with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis. The Journal of Rheumatology. PMID 30647190 DOI: 10.3899/Jrheum.171469  0.391
2017 Beals C, Baumgartner R, Peterfy C, Balanescu A, Mirea G, Harabagiu A, Popa S, Cheng A, Feng D, Ashton E, DiCarlo J, Vallee MH, Dardzinski BJ. Magnetic resonance imaging of the hand and wrist in a randomized, double-blind, multicenter, placebo-controlled trial of infliximab for rheumatoid arthritis: Comparison of dynamic contrast enhanced assessments with semi-quantitative scoring. Plos One. 12: e0187397. PMID 29236711 DOI: 10.1371/Journal.Pone.0187397  0.5
2017 Waterton JC, Ho M, Nordenmark LH, Jenkins M, DiCarlo J, Guillard G, Roberts C, Buonaccorsi G, Parker GJ, Bowes MA, Peterfy C, Kellner H, Taylor PC. Repeatability and response to therapy of dynamic contrast-enhanced magnetic resonance imaging biomarkers in rheumatoid arthritis in a large multicentre trial setting. European Radiology. PMID 28116513 DOI: 10.1007/S00330-017-4736-9  0.431
2016 Peterfy C, Strand V, Tian L, Østergaard M, Lu Y, DiCarlo J, Countryman P, Deodhar A, Landewé R, Ranganath VK, Troum O, Conaghan PG. Short-term changes on MRI predict long-term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trials. Annals of the Rheumatic Diseases. PMID 27974302 DOI: 10.1136/Annrheumdis-2016-210311  0.378
2016 Peterfy C, Burmester GR, Bykerk VP, Combe BG, DiCarlo JC, Furst DE, Huizinga TW, Wong DA, Conaghan PG, Emery P. Sustained improvements in MRI outcomes with abatacept following the withdrawal of all treatments in patients with early, progressive rheumatoid arthritis. Annals of the Rheumatic Diseases. PMID 26865601 DOI: 10.1136/Annrheumdis-2015-208258  0.402
2014 MacIsaac KD, Baumgartner R, Kang J, Loboda A, Peterfy C, DiCarlo J, Riek J, Beals C. Pre-treatment whole blood gene expression is associated with 14-week response assessed by dynamic contrast enhanced magnetic resonance imaging in infliximab-treated rheumatoid arthritis patients. Plos One. 9: e113937. PMID 25504080 DOI: 10.1371/Journal.Pone.0113937  0.417
2014 Peterfy C, Emery P, Tak PP, Ostergaard M, DiCarlo J, Otsa K, Navarro Sarabia F, Pavelka K, Bagnard MA, Gylvin LH, Bernasconi C, Gabriele A. MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study. Annals of the Rheumatic Diseases. PMID 25355728 DOI: 10.1136/Annrheumdis-2014-206015  0.452
2014 Conaghan PG, Peterfy C, Olech E, Kaine J, Ridley D, Dicarlo J, Friedman J, Devenport J, Troum O. The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy. Annals of the Rheumatic Diseases. 73: 810-6. PMID 24525910 DOI: 10.1136/Annrheumdis-2013-204762  0.452
2014 MacIsaac KD, Baumgartner R, Kang J, Loboda A, Peterfy C, DiCarlo J, Riek J, Beals C. Pre-treatment whole blood gene expression is associated with 14-week response assessed by dynamic contrast enhanced magnetic resonance imaging in infliximab-treated rheumatoid arthritis patients Plos One. 9. DOI: 10.1371/journal.pone.0113937  0.313
2013 Peterfy CG, Olech E, DiCarlo JC, Merrill JT, Countryman PJ, Gaylis NB. Monitoring cartilage loss in the hands and wrists in rheumatoid arthritis with magnetic resonance imaging in a multi-center clinical trial: IMPRESS (NCT00425932). Arthritis Research & Therapy. 15: R44. PMID 23514433 DOI: 10.1186/Ar4202  0.454
2013 Conaghan PG, Durez P, Alten RE, Burmester GR, Tak PP, Klareskog L, Catrina AI, DiCarlo J, Gaillez C, Le Bars M, Zhou X, Peterfy C. Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: The ASSET randomised controlled trial Annals of the Rheumatic Diseases. 72: 1287-1294. PMID 22915624 DOI: 10.1136/Annrheumdis-2012-201611  0.403
2013 Beals C, Baumgartner R, Peterfy C, Balanescu A, Mirea G, Harabagiu A, Popa S, Cheng A, Feng D, Fox R, Vallee M-, Ashton E, DiCarlo J, Dardzinski B. SAT0492 Treatment Effects Measured by Dynamic Contrast Enhanced MRI and Ramris for Rheumatoid Arthritis Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-Eular.2216  0.492
2013 Olech E, Peterfy C, DiCarlo J, Sagliani J, Genovese A, Gaylis N. FRI0495 Magnetic resonance imaging may be helpful in predicting long term efficacy of certolizumab pegol in patients with active rheumatoid arthritis Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-Eular.1622  0.458
2013 DiCarlo JC, Hargreaves BA, Pauly KB, Basilio J, Countryman PJ, Peterfy CG. AB1271 Single field-of-view MRI technique for rheumatoid arthritis clinical trials shortens hand/wrist imaging time Annals of the Rheumatic Diseases. 71: 710-710. DOI: 10.1136/Annrheumdis-2012-Eular.1267  0.558
2012 Peterfy CG, DiCarlo JC, Olech E, Bagnard MA, Gabriele A, Gaylis N. Evaluating joint-space narrowing and cartilage loss in rheumatoid arthritis by using MRI. Arthritis Research & Therapy. 14: R131. PMID 22647501 DOI: 10.1186/Ar3861  0.471
2011 Peterfy CG, Countryman P, Gabriele A, Shaw T, Anisfeld A, Tsuji W, Olech E, Gaylis NB, Conaghan PG, Strand V, Dicarlo J. Magnetic resonance imaging in rheumatoid arthritis clinical trials: Emerging patterns based on recent experience Journal of Rheumatology. 38: 2023-2030. PMID 21885511 DOI: 10.3899/Jrheum.110418  0.474
2011 Genovese MC, Kavanaugh A, Weinblatt ME, Peterfy C, Dicarlo J, White ML, O'Brien M, Grossbard EB, Magilavy DB. An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: A three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents Arthritis and Rheumatism. 63: 337-345. PMID 21279990 DOI: 10.1002/Art.30114  0.406
2011 Peterfy CG, Wu C, Szechinski J, Dicarlo JC, Lu Y, Genovese M, Strand V, Genant HK. Comparison of the Genant-modified Sharp and van der Heijde-modified Sharp scoring methods for radiographic assessment in rheumatoid arthritis International Journal of Clinical Rheumatology. 6: 15-24. DOI: 10.2217/Ijr.11.1  0.347
2005 DiCarlo JC, Hargreaves BA, Nayak KS, Hu BS, Pauly JM, Nishimura DG. Variable-density one-shot Fourier velocity encoding. Magnetic Resonance in Medicine. 54: 645-55. PMID 16088883 DOI: 10.1002/Mrm.20594  0.487
Show low-probability matches.